Skip to content
zameds

Methylprednisolone aceponate (Advantan Scalp, Advantan Milk, Advantan, Advantan Fatty)

Methylprednisolone aceponate

Adcock ingram limited

S4Read from the PI-PIL document and verified

Registration

Applicant
Adcock ingram limited
Registrations
5
Schedule source
SAHPRA documentation

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Advantan scalp solution

EACH 1,0 ml SOLUTION CONTAINS: METHYLPREDNISOLONE ACEPONATE 1,0 mg

Solution32036132/13.4.1/0361CancelledNot determinedNone
Advantan milk

EACH 100,0 g EMULSION CONTAINS METHYLPREDNISOLONE ACEPONATE 100,0 mg

1 mg / gEmulsion.32036232/13.4.1/0362Approved 8 May 2023RegisteredNot determinedPIPIL
Advantan cream

EACH 1 g CREAM CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg

1mgCream. Ointment. Fatty ointmentX0384X/13.4.1/384Approved 8 May 1992RegisteredS4PI
Advantan ointment

EACH 1 g OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg

OintmentX0385X/13.4.1/385RegisteredNot determinedNone
Advantan fatty ointment

EACH 1 g OINTMENT CONTAINS METHYLPREDNISOLONE ACEPONATE 1 mg

OintmentX0386X/13.4.1/386RegisteredNot determinedNone

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C27H36O7472.60 g/mol

[(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2-Acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate

Drag to rotate. Structure from PubChem CID 63019.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles